Related Experiment Videos
Isolation of multipotent cells from human term placenta.
B Linju Yen1, Hsing-I Huang, Chih-Cheng Chien
1Stem Cell Research Center, National Health Research Institutes, Min-Chuan E. Road, Taipei, 114, Taiwan.
Stem Cells (Dayton, Ohio)
|December 31, 2004
Summary
Researchers discovered placenta-derived multipotent cells (PDMCs) as a promising stem cell source. These cells offer an ethically sound, accessible alternative to embryonic stem cells (ESCs) and adult stem cells (ASCs).
Area of Science:
- Stem cell biology
- Regenerative medicine
- Placental research
Background:
- Embryonic stem cells (ESCs) face ethical concerns and tumorigenicity risks.
- Adult stem cells (ASCs) may have limited differentiation potential.
- A need exists for ethically sourced, accessible, and high-yielding stem cells.
Purpose of the Study:
- To isolate and characterize multipotent cells from the human term placenta.
- To evaluate placenta-derived multipotent cells (PDMCs) as an alternative stem cell source.
Main Methods:
- Isolation of cells from human term placenta.
- Characterization of cell surface markers (CD105, SH-2, SH-3, SH-4, SSEA-4, TRA-1-61, TRA-1-80).
- Assessment of differentiation potential (adipogenic, osteogenic, neurogenic).
Main Results:
- PDMCs express mesenchymal stem cell markers (CD105, SH-2, SH-3, SH-4).
- PDMCs lack hematopoietic, endothelial, and trophoblastic markers.
- PDMCs exhibit embryonic stem cell markers (SSEA-4, TRA-1-61, TRA-1-80).
- PDMCs successfully differentiated into adipocytes, osteocytes, and neurons.
Conclusions:
- Placenta-derived multipotent cells (PDMCs) represent an ethically uncontroversial stem cell source.
- PDMCs are easily accessible and possess multipotent differentiation capabilities.
- PDMCs hold significant potential for future experimental and clinical applications.